Zurueck zur Suche

Reporte zur Charge U020238

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

21Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
AR 4 LA 3 PA 3 FL 2 GA 2 TN 1 NJ 1 MA 1 MN 1 TX 1 WI 1

VAERS 2409949

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

schwer
Staat
TN
Alter
1,3
Geschlecht
F
Eingang
12.08.2022
Impfdatum
09.08.2022
Beginn
10.08.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Febrile convulsion Laboratory test

Symptomtext

Febrile seizure at 3:10 am lasting 2 minutes per dad report. Patient remained conscious, did not suffer from injury. Emergency medical services were called and patient's vitals were normal (values not known) per dad report.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Febrile convulsion
Hospital-Tage
-
Labordaten
Seen in primary care clinic 8/10/22, neurological tests performed, patient was alert, awake, and oriented, happy and smiling. No laboratory or medical tests beyond physical examination or vital completed.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282923

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

mild
Staat
-
Alter
1,4
Geschlecht
F
Eingang
18.05.2022
Impfdatum
25.04.2022
Beginn
02.05.2022
Tage bis Beginn
7,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Rash Urticaria

Symptomtext

All over body rash, described as hives

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
NAM
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2251977

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

mild
Staat
NJ
Alter
21,0
Geschlecht
M
Eingang
26.04.2022
Impfdatum
26.04.2022
Beginn
26.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Feeling hot Immediate post-injection reaction Lip swelling Mouth swelling Nausea

Symptomtext

Nausea immediately after vaccine pt stated he drank some water and the nausea went away, roughly 5 minutes later he reported his mouth/lips started to feel hot and swollen. The patient was given Benadryl. vitals remained stable, no difficulty breathing or swallowing.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Nausea
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
COMMON COLD
Vorgeschichte
NONE
Andere Medikamente
MUCINEX, FLONASE
Allergien
NONE KNOWN
Vorherige Impfungen
-

VAERS 2187605

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

mild
Staat
FL
Alter
5,0
Geschlecht
F
Eingang
18.03.2022
Impfdatum
15.03.2022
Beginn
15.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cough Culture throat Headache Streptococcus test negative Tonsillar erythema Tonsillar hypertrophy Urticaria

Symptomtext

She developed a slight cough and slight headache on 3/17/22. She went to daycare today (3/18/22)and developed hives on her legs and neck. No known exposure to any food allergens. Her tonsils are red and swollen, she was tested for strep; the rapid strep is negative and throat culture is pending.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
no
Vorgeschichte
Atopic dermatitis, history of Kawasaki disease diagnosed February 2020
Andere Medikamente
Zyrtec
Allergien
Dairy, eggs,peanuts ,soy and wheat
Vorherige Impfungen
-

VAERS 2036158

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

mild
Staat
LA
Alter
1,0
Geschlecht
M
Eingang
14.01.2022
Impfdatum
14.01.2022
Beginn
14.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dermatitis diaper Rash Rash macular

Symptomtext

After patient awoke from daily nap, noted to have macular erythematous flat rash mostly on trunk, a little on extremities, diaper area also. No respiratory distress, no wheeze, no swelling of mucosal membranes, no scrotal swelling, no vomiting or diarrhea. Pulse ox was 97%.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Dad was COVID positive about 3 weeks prior, but patient tested negative. He had symptoms of cough and runny nose and mild fever.
Vorgeschichte
Eczema
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2659460

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

gering
Staat
MA
Alter
-
Geschlecht
U
Eingang
21.07.2023
Impfdatum
17.07.2023
Beginn
17.07.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No Adverse Event; Nurse reports patient was accidently administered an expired dose of VARIVAX on Jul 17, 2023. Product expired on Jun 28, 2023. Product had no prior temperature excursions. No further information provided. No additional AE reported. No PQC reported.; This spontaneous report was received from a nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 17-JUL-2023, the patient was vaccinated with one dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot #U020238, expiration date: 28-JUN-2023 (exact dose, route of administration and anatomical location were not reported) for prophylaxis. The reporter informed that the was accidently administered an expired dose of vaccine (expired product administered). No prior temperature excursion had occurred. There were no additional adverse events reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2568631

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

gering
Staat
MN
Alter
0,8
Geschlecht
M
Eingang
26.01.2023
Impfdatum
25.01.2023
Beginn
25.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

Client received MMR and varicella vaccines too early at age 10 months. No adverse effects reported at this time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Down Syndrome
Andere Medikamente
-
Allergien
None
Vorherige Impfungen
-

VAERS 2386669

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

gering
Staat
GA
Alter
-
Geschlecht
U
Eingang
23.07.2022
Impfdatum
-
Beginn
28.03.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; HCP reported VARIVAX was administered to patient after a temperature excursion.; This spontaneous report was received from a nurse regarding a patient of an unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with an improper storage dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U020238, expiration date: 28-JUN-2023 (dose regimen, route of administration and anatomical location were not provided), as prophylaxis (Product storage error). No adverse events (No adverse event) or product quality complains were reported. The improper storage lot # underwent a temperature excursion of -8.3 degrees Celsius (C) for about 1 hour and 1 minute without previous excursions. This is one patient of three received from the same reporter.; Sender's Comments: US-009507513-2207USA003330: US-009507513-2207USA003332:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2369867

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
15.07.2022
Impfdatum
-
Beginn
17.06.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Overdose

Symptomtext

Patient had no adverse effects or symptoms from this dose; A dose of PROQUAD and VARIVAX were both given to a patient on the same day; This spontaneous report has been received from a medical assistant regarding to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug/allergy reactions, and concomitant therapies, were not reported. On an unknown date (also reported as 17-JUN-2022), the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA [recombinant human albumin]) (PROQUAD) (strength and route of administration not reported) (lot number U029320 with expiration date 19-MAR-2023) administered at a dose of 0.5 mL, once, for prophylaxis and varicella virus vaccine live (oka/merck) (VARIVAX) (strength and route of administration were not reported) (lot number U020238 with expiration date 28-JUN-2023) administered at a dose of 0.5 mL, once, for prophylaxis. The medical assistant reported that on the day of vaccination, both doses of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA [recombinant human albumin]) (PROQUAD) and varicella virus vaccine live (oka/merck) (VARIVAX) were administered to the patient (overdose). The patient did not have adverse effects (no adverse event) or symptoms from this dose.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2270690

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

gering
Staat
FL
Alter
1,2
Geschlecht
F
Eingang
09.05.2022
Impfdatum
09.05.2022
Beginn
09.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Wrong product administered

Symptomtext

Patient was supposed to receive MMR. Patient received MMRV, when staff realized that wrong vaccine was administered staff called parent to explain what happened and let mom know we will be monitoring the patient for the next 5 to 12 days. Patient at this time was asymptomatic.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
None
Vorherige Impfungen
-

VAERS 2170373

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

gering
Staat
LA
Alter
-
Geschlecht
U
Eingang
10.03.2022
Impfdatum
08.02.2022
Beginn
08.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other concerns or issues noted; improperly stored VARlVAX had been administered; This spontaneous report was received from a customer and refers to a patient of unknown age and gender. No information about the patient's medical history, concomitant medications and concurrent conditions was reported. On 08-FEB-2022, the patient was vaccinated with improperly stored (41 degrees Fahrenheit for 45 minutes) varicella virus vaccine live (oka/merck) (VARIVAX) lot #U020238, expiration date: 28-JUN-2023 (dose, site and route of administration were not provided) for prophylaxis (product storage error). No other concerns or issues were noted (no adverse event).; Sender's Comments: US-009507513-2202USA003311: US-009507513-2202USA003391:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2160502

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

gering
Staat
AR
Alter
1,0
Geschlecht
U
Eingang
05.03.2022
Impfdatum
26.01.2022
Beginn
26.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional adverse events reported; incorrect product storage; This spontaneous report was received from other health professional and refers to 12-months-old patient of unknown gender. There were no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 26-JAN-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (VARIVAX), lot #: U020238, expiration date: 28-JUN-2023, dose: 0,5 milliliter (route of administration and dose number were not reported) for prophylaxis (product storage error). Administered dose of vaccine experienced the temperature excursion between 6 degrees Fahrenheit (F) up to 14 degrees Fahrenheit (F) (13.8 F) for 1 hour, 45 minutes and between of 14 degrees Fahrenheit up to 46 degrees Fahrenheit for (14.4 F) for 25 minutes. There were no previous temperature excursions. No adverse event was reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2151776

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

gering
Staat
WI
Alter
1,8
Geschlecht
F
Eingang
02.03.2022
Impfdatum
01.03.2022
Beginn
01.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Hib vaccine expired on 2/26/22 and was given on 3/1/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2150582

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

gering
Staat
LA
Alter
-
Geschlecht
U
Eingang
01.03.2022
Impfdatum
08.02.2022
Beginn
08.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

no other issues or concerns noted; improperly stored Varivax had been administered; This spontaneous report was received from a office manager and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 08-FEB-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) lot #U020238, expiration date: 28-JUN-2023 (formulation, strength, dose, frequency, site and route of administration were not provided) for prophylaxis (product storage error). The vaccine experienced a temperature excursion of 41 degrees Fahrenheit for 45 minutes. No previous temperature excursions were reported. No other issues or concerns noted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2141851

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

gering
Staat
AR
Alter
1,0
Geschlecht
U
Eingang
26.02.2022
Impfdatum
25.01.2022
Beginn
25.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional adverse events reported; dose of Improperly Stored VARIVAX has been administered to a patient; This spontaneous report as received from a registered nurse refers to a 12-month-old patient. No information regarding the patient's concurrent conditions, medical history, drug allergies and concomitant medications were provided. On 25-JAN-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) lot # U020238, expiration date 25-JUN-2023, dose: 0,5 milliliter (formulation, injection site and route of administration were not provided) for prophylaxis. The the vaccine was stored in inappropriate range of temperature. Temperature and time frame: 6 F (Fahrenheit) degrees up to 14 F degrees (13.8F) for 1 hour 45 minutes and 0 seconds; 14 F degrees up to 46 F degrees (14.4 F) for 0 hours 25 minutes and 0 seconds (product storage error temperature too high). There was no previous temperature excursion. No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2137267

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

gering
Staat
GA
Alter
1,0
Geschlecht
M
Eingang
24.02.2022
Impfdatum
23.02.2022
Beginn
23.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Cough Dysphonia Rhinorrhoea Stridor Swelling face Swelling of eyelid

Symptomtext

Significant coughing, inspiratory stridor, hoarseness, runny nose, (facial) swelling of the right upper eye lid

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cough
Hospital-Tage
-
Labordaten
No labs drawn after reaction
Aktuelle Erkrankungen
Positive COVID PCR test on 1/7/2022
Vorgeschichte
None
Andere Medikamente
None
Allergien
None Known
Vorherige Impfungen
-

VAERS 2109739

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

gering
Staat
AR
Alter
1,0
Geschlecht
U
Eingang
14.02.2022
Impfdatum
26.01.2022
Beginn
26.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional adverse events reported.; Improperly Stored VARIVAX has been administered to a patient; This spontaneous report was received from a registered nurse referring to a 12 months old patient of unknown gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 26-JAN-2022, the patient was vaccinated with a dose of improperly stored (later found supported) varicella virus vaccine live (oka/merck) (VARIVAX) (strength and route of administration were not reported, lot # U020238, expiration date was 28-JUN-2023) 0.5 ml for prophylaxis (product storage error). It was reported that the suspect vaccine was exposed to a temperature of 6 Fahrenheit (F) up to 14 F (13.8 F) for a time frame of 1 hours and 45 minutes and 0 seconds, 14 F up to 46 F (14.4 F) for 0 hours 25 minutes and 0 seconds. There were no previous temperature excursions. No further adverse event (AE) information was provided (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2089715

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

gering
Staat
AR
Alter
-
Geschlecht
U
Eingang
05.02.2022
Impfdatum
31.01.2022
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

Nurse reporting a dose of improperly stored VARIVAX; No additional adverse events reported; This spontaneous information was received from a registered nurse concerning a patient of unknown age and gender. Patient's concurrent conditions, medical history and concomitant medications were not provided. On 31-JAN-2022, the patient received an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml for prophylaxis, lot number: U020238 with expiration date on 28-JUN-2023 (strength, frequency, route of administration and anatomical location were not provided) (incorrect product storage). The varicella virus vaccine live (oka/merck) (VARIVAX) was stored at a temperature range of 6 degrees Fahrenheit (F) up to 14 degrees Fahrenheit (13.8F) for the time frame of 1 hour and 45 minutes and 0 seconds, and for the temperature range of 14F up to 46F (14.4F) for 0 hours 25 minutes and 0 seconds. There was no previous temperature excursion. No additional adverse events reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2084626

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

gering
Staat
PA
Alter
-
Geschlecht
U
Eingang
03.02.2022
Impfdatum
21.12.2021
Beginn
21.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Varivax exposed to a temperature excursion was administered; This spontaneous report was received from a physician concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 21-DEC-2021 the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # U020238 with expiration date: 28-JUN-2023, (dose, route of administration not reported) as prophylaxis, that had experienced a temperature excursion at 8.2 Fahrenheit degrees for 1 hour and 30 minutes. There were no previous temperature excursions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2075129

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

gering
Staat
PA
Alter
-
Geschlecht
U
Eingang
31.01.2022
Impfdatum
23.12.2021
Beginn
23.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Temperature 8.2F/ Time frame: 1 hours and 30 minutes; This spontaneous report was received from a physician referring to a patient of unknown age and gender. The patient's concomitant medications, concurrent conditions, medical history and drug reactions/allergies were not reported. On 23-DEC-2021, the patient received improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot # U020238, expiration date: 28-JUN-2023, strength, dose and route were unknown) for prophylaxis (product storage error). The vaccine was stored at 8.2 degrees Fahrenheit (F) for one hour and 30 minutes. There was no previous excursion.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2023945

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U020238

gering
Staat
PA
Alter
-
Geschlecht
U
Eingang
11.01.2022
Impfdatum
21.12.2021
Beginn
21.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Temperature 8.2F/ Time frame: 1 hours and 30 minutes; This spontaneous report has been received from a physician referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant therapies and previous drug reactions or allergies were not reported. On 21-DEC-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) (dose, route of administration, anatomical site of vaccination and vaccine scheme were not reported; lot number U020238 has been verified to be valid, expiration date reported and established as 28-JUN-2023) as prophylaxis. The vaccine was exposed to a temperature excursion of 8.2 degrees Fahrenheit, during a time frame of 1 hour and 30 minutes (product storage error). There was no previous temperature excursion.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-